/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
/f/125658/5276x1732/1c0638c6a5/eapci-acronym-name-rgb.jpg)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Effect of pcsk9 antibodies on neurocognitive outcomes and improved survival in patients at higher risk: a meta-analysis of randomised controlled trials
Event: ESC Congress 2016
Topic: Drug therapy
Session: Lipid-lowering agents - New perspectives
ESC 365 is supported by
